{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:58:56Z","timestamp":1772038736961,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY1184"],"award-info":[{"award-number":["2022KY1184"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1602"],"award-info":[{"award-number":["2024KY1602"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1601"],"award-info":[{"award-number":["2024KY1601"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.transci.2025.104096","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:23:53Z","timestamp":1739791433000},"page":"104096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Etoposide +\u202fcytarabine +\u202fpegfilgrastim versus cyclophosphamide +\u202fG-CSF for stem cell mobilization in patients with poorly mobilized multiple myeloma and lymphoma"],"prefix":"10.1016","volume":"64","author":[{"given":"Yixuan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sishi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzhi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianxu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3050-0738","authenticated-orcid":false,"given":"Peipei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.transci.2025.104096_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41375-022-01563-8","article-title":"The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years","volume":"36","author":"Bazarbachi","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.transci.2025.104096_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040863","article-title":"Role of Stem Cell Transplantation in Multiple Myeloma","volume":"13","author":"Devarakonda","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.transci.2025.104096_bib3","first-page":"850","article-title":"Current status of art mobilization in Myeloma","volume":"56","author":"Sevindik","year":"2017","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"9","key":"10.1016\/j.transci.2025.104096_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"7","key":"10.1016\/j.transci.2025.104096_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/bmt.2012.269","article-title":"Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers","volume":"48","author":"Giebel","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2025.104096_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bmt.2009.119","article-title":"Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization","volume":"45","author":"Dugan","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2025.104096_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.leukres.2010.12.036","article-title":"Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: a REL (Rete Ematologica Lombarda) experience","volume":"35","author":"Arcaini","year":"2011","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.transci.2025.104096_bib8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/bmt.2010.254","article-title":"Outcome, toxicity profile and cost analysis of autologous stem cell mobilization","volume":"46","author":"Jagasia","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2025.104096_bib9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1537-2995.2011.03176.x","article-title":"Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation","volume":"51","author":"Hosing","year":"2011","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2025.104096_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1083-8791(00)70021-8","article-title":"Favorable treatment outcome in non-Hodgkin's lymphoma patients with \"poor\" mobilization of peripheral blood progenitor cells","volume":"6","author":"Stockerl-Goldstein","year":"2000","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"8","key":"10.1016\/j.transci.2025.104096_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jcyt.2023.04.014","article-title":"Higher efficacy of Etoposide +\u202fCytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients","volume":"25","author":"Ye","year":"2023","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2021.03.01","article-title":"Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)","volume":"33","author":"Zhu","year":"2021","journal-title":"Chin J Cancer Res =\u202fChung-kuo yen cheng yen chiu"},{"issue":"9","key":"10.1016\/j.transci.2025.104096_bib13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bmt.2011.82","article-title":"Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo","volume":"47","author":"Olivieri","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+\u202fcell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Sutherland","year":"1996","journal-title":"Hematother"},{"issue":"7","key":"10.1016\/j.transci.2025.104096_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2025.104096_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res Integr peer Rev"},{"key":"10.1016\/j.transci.2025.104096_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19367","article-title":"Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: a prospective multicentre study","author":"Ye","year":"2024","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.transci.2025.104096_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144169","article-title":"Correlation of Body Mass Index and Proinflammatory Cytokine Levels with Hematopoietic Stem Cell Mobilization","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.transci.2025.104096_bib21","first-page":"77","article-title":"Plerixafor use in patients with previous mobilization failure: A multicenter experience","volume":"47","author":"Tekg\u00fcnd\u00fcz","year":"2012","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib22","article-title":"Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study","volume":"27","author":"Zannetti","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transci.2025.104096_bib23","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.284023","article-title":"A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents","author":"Mina","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.transci.2025.104096_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbmt.2011.07.014","article-title":"Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma","volume":"18","author":"Attolico","year":"2012","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"12","key":"10.1016\/j.transci.2025.104096_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S1470-2045(21)00535-0","volume":"22","author":"Gay","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.transci.2025.104096_bib26","first-page":"318","article-title":"Intermediate-dose cytarabine plus G-CSF as mobilization regimen for newly diagnosed multiple myeloma and heavily pre-treated patients with hematological and non-hematological malignancies","volume":"58","author":"Callera","year":"2019","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"2","key":"10.1016\/j.transci.2025.104096_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbmt.2018.09.023","article-title":"Increased efficacy of stem cell chemomobilization with intermediate-dose cytarabine plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone in patients with multiple myeloma: results of a randomized trial","volume":"25","author":"Czerw","year":"2019","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"7","key":"10.1016\/j.transci.2025.104096_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41409-018-0396-x","article-title":"Cytarabine\u202f+\u202fG-CSF is more effective than cyclophosphamide\u202f+\u202fG-CSF as a stem cell mobilization regimen in multiple myeloma","volume":"54","author":"Jelinek","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2025.104096_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00277-019-03800-0","article-title":"Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma","volume":"99","author":"Ding","year":"2020","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2025.104096_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bmt.2014.297","article-title":"Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis","volume":"50","author":"Kim","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transci.2025.104096_bib31","first-page":"2891","article-title":"Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial","volume":"23","author":"Masuda","year":"2015","journal-title":"Support Care Cancer: J Multinatl Assoc Support Care Cancer"},{"issue":"1","key":"10.1016\/j.transci.2025.104096_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1704702","article-title":"Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma","volume":"35","author":"Steidl","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2025.104096_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1537-2995.2006.00699.x","article-title":"A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+\u202fprogenitors in patients with multiple myeloma","volume":"46","author":"Bruns","year":"2006","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:24:56Z","timestamp":1762547096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050225000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1473050225000308"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2025.104096","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etoposide +\u202fcytarabine +\u202fpegfilgrastim versus cyclophosphamide +\u202fG-CSF for stem cell mobilization in patients with poorly mobilized multiple myeloma and lymphoma","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2025.104096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104096"}}